indazoles has been researched along with Diabetic Glomerulosclerosis in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jeon, SY; Lee, NR; Yim, CY | 1 |
| Barnes, J; Block, K; Cavaglierii, RC; Friedrichs, WE; Nayak, BK; Patel, M; Shanmugasundaram, K | 1 |
| Bhattacharya, SK; Boehm, M; Borzilleri, KA; Brown, JA; Calabrese, M; Cameron, KO; Caspers, NL; Cokorinos, E; Conn, EL; Dowling, MS; Edmonds, DJ; Eng, H; Fernando, DP; Frisbie, R; Hepworth, D; Kalgutkar, AS; Kung, DW; Kurumbail, RG; Landro, J; Mao, Y; Miller, R; Rajamohan, F; Reyes, AR; Rose, CR; Ryder, T; Salatto, CT; Shavnya, A; Smith, AC; Tu, M; Ward, J; Withka, JM; Wolford, AC; Xiao, J | 1 |
| Blantz, RC; Deng, A; Gabbai, FB; Hammes, JS; Komine, N; Thomson, SC | 1 |
| Jiang, SJ; Li, LM; Qiu, J; Shen, JP; Wu, HW; Yin, XX; Zhang, YD; Zheng, XG; Zhu, X | 1 |
5 other study(ies) available for indazoles and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Successful re-administration of Pazopanib in a patient with metastatic renal cell carcinoma and a history of Pazopanib-induced nephrotic syndrome: a case report.
Topics: Aged; Amlodipine; Angiogenesis Inhibitors; Antihypertensive Agents; Antineoplastic Agents; Carcinoma, Renal Cell; Combined Modality Therapy; Diabetic Nephropathies; Dihydropyridines; Drug Substitution; Edema; Everolimus; Humans; Hypertension; Indazoles; Kidney Failure, Chronic; Lung Neoplasms; Male; Nephrotic Syndrome; Nivolumab; Pancreatic Neoplasms; Pancreaticoduodenectomy; Pneumonectomy; Protein Kinase Inhibitors; Pyrimidines; Sirolimus; Sulfonamides; Sunitinib | 2019 |
HIF-1 Mediates Renal Fibrosis in OVE26 Type 1 Diabetic Mice.
Topics: Animals; Antioxidants; Cell Line; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Extracellular Matrix; Fibrosis; Gene Expression Regulation; Glucose Transporter Type 1; Hyperglycemia; Hypoglycemia; Hypoglycemic Agents; Hypoxia-Inducible Factor 1, alpha Subunit; Indazoles; Kidney; Mesangial Cells; Mice, Transgenic; NADPH Oxidase 4; NADPH Oxidases; Oxidative Stress; Recombinant Proteins; Renal Insufficiency; RNA Interference | 2016 |
Discovery and Preclinical Characterization of 6-Chloro-5-[4-(1-hydroxycyclobutyl)phenyl]-1H-indole-3-carboxylic Acid (PF-06409577), a Direct Activator of Adenosine Monophosphate-activated Protein Kinase (AMPK), for the Potential Treatment of Diabetic Neph
Topics: Administration, Oral; Adsorption; AMP-Activated Protein Kinases; Animals; Crystallography, X-Ray; Diabetic Nephropathies; Dogs; Enzyme Activators; High-Throughput Screening Assays; Humans; Indazoles; Indoles; Injections, Intravenous; Macaca fascicularis; Male; Models, Molecular; Protein Conformation; Rats | 2016 |
Early diabetes as a model for testing the regulation of juxtaglomerular NOS I.
Topics: Animals; Diabetic Nephropathies; Enzyme Inhibitors; Feedback, Physiological; Glomerular Filtration Rate; Indazoles; Juxtaglomerular Apparatus; Male; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; omega-N-Methylarginine; Rats; Rats, Wistar; Renal Circulation | 2004 |
Protective effects of bendazac lysine on early experimental diabetic nephropathy in rats.
Topics: Aldehyde Reductase; Animals; Diabetic Nephropathies; Erythrocytes; Glomerular Mesangium; Glycation End Products, Advanced; Indazoles; Kidney; Laminin; Male; Oxidative Stress; Rats; Rats, Sprague-Dawley; RNA, Messenger; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2005 |